Ismail Shehada

Ismail's distinguished career spans over 25 years in senior management roles, with a decade dedicated to strategic planning, operational efficiency, business development, and manufacturing in the pharmaceutical sector across diverse regions and therapeutic domains. Currently serving as the CEO of Tabuk Pharmaceuticals, Ismail previously held the position of Chief Executive Officer (CEO) of the Pharma sector within the Saudi Chemical Holding Group (SCCH). His leadership extends to roles as chairman and board director of the Care Supply Chain, a joint venture with a prestigious German company. Prior to his current roles, Ismail made significant contributions as the Country President for the Gulf Cooperation Council & Pakistan cluster at AstraZeneca, and as the Country Manager for Saudi Arabia at GlaxoSmithKline (GSK). Ismail's impact on the Saudi Pharmaceutical industry is evident through his leadership in the private sector sub-committee at the National Committee for Pharmaceutical Industries (NCPI) and as Vice Chairman of the Research-Based Pharmaceutical Companies (RPCC). He has played a pivotal role in advocacy projects and shaping health policy issues in Saudi Arabia.